These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bleeding disorder due to platelet prostaglandin H synthase-1 (PGHS-1) deficiency. Matijevic-Aleksic N; McPhedran P; Wu KK Br J Haematol; 1996 Jan; 92(1):212-7. PubMed ID: 8562397 [TBL] [Abstract][Full Text] [Related]
3. Long-term untreated streptozotocin-diabetes leads to increased expression and elevated activity of prostaglandin H2 synthase in blood platelets. Siewiera K; Kassassir H; Talar M; Wieteska L; Watala C Platelets; 2016; 27(3):203-11. PubMed ID: 26325148 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of thromboxane A synthase and prostaglandin H synthase in megakaryocytic cell line. Matijevic-Aleksic N; Sanduja SK; Wang LH; Wu KK Biochim Biophys Acta; 1995 Nov; 1269(2):167-75. PubMed ID: 7488650 [TBL] [Abstract][Full Text] [Related]
5. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets. Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Vezza R; Mezzasoma AM; Venditti G; Gresele P Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439 [TBL] [Abstract][Full Text] [Related]
7. Suppressed thromboxane production in endotoxin-desensitized THP-1 cells is not a result of decreased prostaglandin H synthase activity. Durando M; Fernando L; Ashton S; Halushka P; Cook J Shock; 1998 May; 9(5):359-63. PubMed ID: 9617886 [TBL] [Abstract][Full Text] [Related]
8. Familial bleeding tendency with partial platelet thromboxane synthetase deficiency: reorientation of cyclic endoperoxide metabolism. Defreyn G; Machin SJ; Carreras LO; Dauden MV; Chamone DA; Vermylen J Br J Haematol; 1981 Sep; 49(1):29-41. PubMed ID: 6268139 [TBL] [Abstract][Full Text] [Related]
9. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity. Hirakata H; Ushikubi F; Toda H; Nakamura K; Sai S; Urabe N; Hatano Y; Narumiya S; Mori K Anesthesiology; 1996 Dec; 85(6):1447-53. PubMed ID: 8968193 [TBL] [Abstract][Full Text] [Related]
10. Endogenous peroxynitrite modulates PGHS-1-dependent thromboxane A2 formation and aggregation in human platelets. Schildknecht S; van der Loo B; Weber K; Tiefenthaler K; Daiber A; Bachschmid MM Free Radic Biol Med; 2008 Aug; 45(4):512-20. PubMed ID: 18514074 [TBL] [Abstract][Full Text] [Related]
11. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists. Hanasaki K; Arita H Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322 [TBL] [Abstract][Full Text] [Related]
12. Familial and constitutional bleeding disorder due to platelet cyclo-oxygenase deficiency. Horellou MH; Lecompte T; Lecrubier C; Fouque F; Chignard M; Conard J; Vargaftig BB; Dray F; Samama M Am J Hematol; 1983 Feb; 14(1):1-9. PubMed ID: 6404162 [TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 synthase activity in platelet free human monocytes. Orlandi M; Bartolini G; Belletti B; Spisni E; Tomasi V Biochim Biophys Acta; 1994 Dec; 1215(3):285-90. PubMed ID: 7811713 [TBL] [Abstract][Full Text] [Related]
14. Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries. Davidge ST; Zhang Y Circ Res; 1998 Aug; 83(4):388-95. PubMed ID: 9721695 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
16. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant. Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555 [TBL] [Abstract][Full Text] [Related]
17. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets. Mayeux PR; Morton HE; Gillard J; Lord A; Morinelli TA; Boehm A; Mais DE; Halushka PV Biochem Biophys Res Commun; 1988 Dec; 157(2):733-9. PubMed ID: 2974286 [TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction. Parise LV; Venton DL; Le Breton GC J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669 [TBL] [Abstract][Full Text] [Related]
19. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man. Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169 [TBL] [Abstract][Full Text] [Related]
20. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Cipollone F; Patrignani P; Greco A; Panara MR; Padovano R; Cuccurullo F; Patrono C; Rebuzzi AG; Liuzzo G; Quaranta G; Maseri A Circulation; 1997 Aug; 96(4):1109-16. PubMed ID: 9286937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]